SCHEMBL447116

SCHEMBL447116

CN(C=NN)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2192119 1.00
Water SCHEMBL4457971 0.98 TDP1 (0.32)
SCHEMBL27413038 0.74
Bromide SCHEMBL7533249 0.73 TDP1 (0.33)
SCHEMBL207502 0.70
SCHEMBL2124031 0.70 MVD (0.33)
SCHEMBL10527747 0.69
Hydrochloric Acid SCHEMBL27651914 0.69
SCHEMBL14107062 0.69
SCHEMBL1287272 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3838902-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR PRODUCING SAME AND USE OF SAME TriOptoTec GmbH (DE) 2021-06-23 EP claimed
US-20130116211-A1 Novel Salts Of Boswellic Acids And Selectively Enriched Boswellic Acids And Processes For The Same GOKARAJU GANGA RAJU (IN) 2013-05-09 US claimed
US-20090042832-A1 NOVEL SALTS OF BOSWELLIC ACIDS AND SELECTIVELY ENRICHED BOSWELLIC ACIDS AND PROCESSES FOR THE SAME LAILA IMPEX (IN) 2009-02-12 US claimed
WO-2006095355-A1 NOVEL SALTS OF BOSWELLIC ACIDS AND SELECTIVELY ENRICHED BOSWELLIC ACIDS AND PROCESSES FOR THE SAME GOKARAJU GANGA RAJU (IN) 2006-09-14 WO claimed
US-20260137645-A1 HIGHLY PURIFIED (R)-3’-HYDROXYBUTYL (R)-3’-HYDROXYBUTYRATE AND (R)-3-HYDROXYBUTYRATE AND COMBINATIONS WITH THERAPEUTICS Ketone Catalyst Innovations, LLC (US) 2026-05-21 US disclosed
US-20260124165-A1 COMPOSITIONS COMPRISING CREATINE FOR USE IN TELOMERE LENGTHENING OSTOJIC SERGEJ (RS) 2026-05-07 US disclosed
US-12582623-B2 Composition comprising EPA, MA and leucine for improving muscle function N.V. NUTRICIA (NL) 2026-03-24 US disclosed
EP-4522144-B1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES ALZCHEM TROSTBERG GMBH (DE) 2026-03-11 EP disclosed
US-12568993-B2 Shelf-stable nitrogenous organic acid compositions GLANBIA DAIRY NUTRITION LIMITED (IE) 2026-03-10 US disclosed
US-20250325505-A1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF BREATHING DIFFICULTIES ALZCHEM TROSTBERG GMBH (DE) 2025-10-23 US disclosed
US-20250302788-A1 COMPOSITION COMPRISING CREATINE FOR USE IN THE TREATMENT OF POST VIRAL FATIGUE SYNDROME ALZCHEM TROSTBERG GMBH (DE) 2025-10-02 US disclosed
EP-3773013-B1 INSULIN CONTROL IN OVERWEIGHT OR OBESE ADULT DURING LIFE TIME INTERVENTION NUTRICIA NV (NL) 2025-04-30 EP disclosed
WO-1997013507-A1 USE OF CREATINE ANALOGUES FOR THE TREATMENT OF DISORDERS OF GLUCOSE METABOLISM AVICENA GROUP, INC. (US) 1997-04-17 WO disclosed
US-5612375-A Creatine beverage and producing process thereof IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. (JP) 1997-03-18 US disclosed
US-5576316-A Method for inhibiting tumor growth rate using creatine or creatine analogs UNIVERSITY OF PENNSYLVANIA (US) 1996-11-19 US disclosed
WO-1996014063-A1 USE OF CREATINE OR CREATINE ANALOGS FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM AVICENA GROUP, INC. (US) 1996-05-17 WO disclosed
WO-1996004240-A1 HYDROSOLUBLE ORGANIC SALTS OF CREATINE FLAMMA S.P.A. (IT) 1996-02-15 WO disclosed
EP-0669083-A2 Creatine beverage and producing process thereof Sueoka, Haruhiko (JP) 1995-08-30 EP disclosed
WO-1994016687-A1 USE OF CREATINE OR ANALOGS FOR THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING TUMOR GROWTH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1994-08-04 WO disclosed
US-4620941-A CHROMOGEN, DEVELOPER, DESENSITIZER SAKURA COLOR PRODUCTS CORPORATION (JP) 1986-11-04 US disclosed